Visgeneer Cash Flow Conversion Efficiency

Latest as of June 2024: -0.060x

Visgeneer cash flow conversion efficiency. Based on the latest financial reports, Visgeneer (4197) has a cash flow conversion efficiency ratio of -0.060x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-11.86 Million ≈ $-373.78K USD) by net assets (NT$197.35 Million ≈ $6.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Visgeneer (2012–2025)

Cash flow conversion efficiency of Visgeneer from 2012 to 2025. This chart illustrates how Visgeneer's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Visgeneer stock quote for real-time trading data and today's change.

Visgeneer Cash Flow Conversion Ratio Explained

Visgeneer cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Visgeneer Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Visgeneer ranked by their cash flow conversion efficiency. Also see 4197 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
DXN Ltd AU:DXN	-0.368x
Muza S.A WAR:MZA	0.068x
Adelong Gold Ltd AU:ADG	-0.066x
PRS Reit PLC LSE:PRSR	0.016x
WALKER RIVER RES CORP F:1WV0	-0.019x
Axolot Solutions Holding AB ST:AXOLOT	-0.008x
Ekiz Kimya Sanayi ve Ticaret AS IS:EKIZ	-0.296x
CYL Corporation Bhd KLSE:7157	0.081x

Annual Cash Flow Conversion Efficiency for Visgeneer (2012–2025)

The table below shows the annual cash flow conversion efficiency of Visgeneer from 2012 to 2025. Review Visgeneer (4197) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$199.09 Million ≈ $6.27 Million	NT$13.37 Million ≈ $421.10K	0.067x	+227.39%
2024-12-31	NT$193.84 Million ≈ $6.11 Million	NT$-10.22 Million ≈ $-321.86K	-0.053x	-184.52%
2023-12-31	NT$211.57 Million ≈ $6.67 Million	NT$13.19 Million ≈ $415.62K	0.062x	-66.90%
2022-12-31	NT$231.16 Million ≈ $7.28 Million	NT$43.55 Million ≈ $1.37 Million	0.188x	+234.16%
2021-12-31	NT$218.81 Million ≈ $6.89 Million	NT$12.34 Million ≈ $388.65K	0.056x	+62.41%
2020-12-31	NT$218.00 Million ≈ $6.87 Million	NT$7.57 Million ≈ $238.40K	0.035x	+164.63%
2019-12-31	NT$217.39 Million ≈ $6.85 Million	NT$-11.68 Million ≈ $-367.83K	-0.054x	-415.42%
2018-12-31	NT$249.15 Million ≈ $7.85 Million	NT$-2.60 Million ≈ $-81.79K	-0.010x	+87.57%
2017-12-31	NT$281.04 Million ≈ $8.85 Million	NT$-23.55 Million ≈ $-742.02K	-0.084x	-182.83%
2016-12-31	NT$311.69 Million ≈ $9.82 Million	NT$31.54 Million ≈ $993.59K	0.101x	+0.27%
2015-12-31	NT$315.69 Million ≈ $9.95 Million	NT$31.86 Million ≈ $1.00 Million	0.101x	+198.67%
2014-12-31	NT$309.25 Million ≈ $9.74 Million	NT$10.45 Million ≈ $329.17K	0.034x	-78.76%
2013-12-31	NT$285.60 Million ≈ $9.00 Million	NT$45.42 Million ≈ $1.43 Million	0.159x	-36.02%
2012-12-31	NT$250.23 Million ≈ $7.88 Million	NT$62.20 Million ≈ $1.96 Million	0.249x	--

About Visgeneer

TWO:4197 Taiwan Biotechnology

Market Cap

$7.54 Million

NT$239.34 Million TWD

Market Cap Rank

#27604 Global

#1586 in Taiwan

Share Price

NT$7.93

Change (1 day)

-3.29%

52-Week Range

NT$7.93 - NT$19.00

All Time High

NT$28.80